Enzymatic versus plasmid DNA for rAAV production: early development insights that lead to manufacturing success
Leticia Agundez, PhD, Elisa Da Silva Ferrada, PhD
Quality agreements, tech transfer, and risk management in cell and gene therapy
Luciana Mansolelli, Audrey Chang, PhD
Addressing AAV purification bottlenecks in 2026
S Jeffers, PhD, A D. Tustian, PhD, S Mohanty, PhD et al.